Eric Olson

Array ( [id] => 7367523 [patent_doc_number] => 20040006053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Method of long-term treatment of Graft-Versus-Host Disease using topical active corticosteriods' [patent_app_type] => new [patent_app_number] => 10/613788 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2338 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006053.pdf [firstpage_image] =>[orig_patent_app_number] => 10613788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468184 [patent_doc_number] => 20040053918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Erythropoietin production potentiator' [patent_app_type] => new [patent_app_number] => 10/607996 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2696 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053918.pdf [firstpage_image] =>[orig_patent_app_number] => 10607996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207597 [patent_doc_number] => 20040087608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Pharmaceuticals for neuropathic pain' [patent_app_type] => new [patent_app_number] => 10/603936 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4723 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087608.pdf [firstpage_image] =>[orig_patent_app_number] => 10603936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473913 [patent_doc_number] => 20040097405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Method of treating cartilage damage' [patent_app_type] => new [patent_app_number] => 10/602413 [patent_app_country] => US [patent_app_date] => 2003-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61657 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097405.pdf [firstpage_image] =>[orig_patent_app_number] => 10602413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306478 [patent_doc_number] => 20040116506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Use of levetiracetam for treating or preventing acute headaches' [patent_app_type] => new [patent_app_number] => 10/600818 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2815 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116506.pdf [firstpage_image] =>[orig_patent_app_number] => 10600818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 535363 [patent_doc_number] => 07176189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-13 [patent_title] => 'Methods for regeneration of a mammalian lens' [patent_app_type] => utility [patent_app_number] => 10/600745 [patent_app_country] => US [patent_app_date] => 2003-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 14517 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/176/07176189.pdf [firstpage_image] =>[orig_patent_app_number] => 10600745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363685 [patent_doc_number] => 08252750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale' [patent_app_type] => utility [patent_app_number] => 10/460170 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11595 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10460170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363685 [patent_doc_number] => 08252750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale' [patent_app_type] => utility [patent_app_number] => 10/460170 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11595 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10460170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363685 [patent_doc_number] => 08252750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale' [patent_app_type] => utility [patent_app_number] => 10/460170 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11595 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10460170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363685 [patent_doc_number] => 08252750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Intrauterine fetal growth restriction—the treatment modalities for clinical research, and the biochemical rationale' [patent_app_type] => utility [patent_app_number] => 10/460170 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11595 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10460170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7097322 [patent_doc_number] => 20050129780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Relief of aids symptoms' [patent_app_type] => utility [patent_app_number] => 10/515773 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6477 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20050129780.pdf [firstpage_image] =>[orig_patent_app_number] => 10515773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851789 [patent_doc_number] => 20060234980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food' [patent_app_type] => utility [patent_app_number] => 10/516234 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5230 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234980.pdf [firstpage_image] =>[orig_patent_app_number] => 10516234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4583776 [patent_doc_number] => 07851450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Gangliosides with a modified acyl function' [patent_app_type] => utility [patent_app_number] => 10/497173 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4531 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851450.pdf [firstpage_image] =>[orig_patent_app_number] => 10497173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5716101 [patent_doc_number] => 20060079464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Peritoneal dialysate containing taurine' [patent_app_type] => utility [patent_app_number] => 10/520243 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3051 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079464.pdf [firstpage_image] =>[orig_patent_app_number] => 10520243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13722 [patent_doc_number] => 07807656 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Pharmaceutical applications of hyaluronic acid preparations' [patent_app_type] => utility [patent_app_number] => 10/495200 [patent_app_country] => US [patent_app_date] => 2003-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3778 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807656.pdf [firstpage_image] =>[orig_patent_app_number] => 10495200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289613 [patent_doc_number] => 20040110296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Conjugates and compositions for cellular delivery' [patent_app_type] => new [patent_app_number] => 10/427160 [patent_app_country] => US [patent_app_date] => 2003-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 52356 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110296.pdf [firstpage_image] =>[orig_patent_app_number] => 10427160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6945269 [patent_doc_number] => 20050197318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Fucose containing proteoglycan or acidic glycan and their pharmaceutical use' [patent_app_type] => utility [patent_app_number] => 10/423855 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8147 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197318.pdf [firstpage_image] =>[orig_patent_app_number] => 10423855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 142469 [patent_doc_number] => 07691986 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'High molecular weight, low methoxyl pectins, and their production and uses' [patent_app_type] => utility [patent_app_number] => 10/422867 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16733 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691986.pdf [firstpage_image] =>[orig_patent_app_number] => 10422867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7200202 [patent_doc_number] => 20050164980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Hyaluronic acid modification product' [patent_app_type] => utility [patent_app_number] => 10/511707 [patent_app_country] => US [patent_app_date] => 2003-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10396 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164980.pdf [firstpage_image] =>[orig_patent_app_number] => 10511707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770408 [patent_doc_number] => 20030216348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Aminosugar, glycosaminoglycan, and S-Adenosylmethionine composition for the treatment and repair of connective tissue' [patent_app_type] => new [patent_app_number] => 10/408255 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7562 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216348.pdf [firstpage_image] =>[orig_patent_app_number] => 10408255 [rel_patent_id] =>[rel_patent_doc_number] =>)